Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Ana Ricobaraza, Lucia Mora-Jimenez, Elena Puerta, Rocio Sanchez-Carpintero, Ana Mingorance, Julio Artieda, Maria Jesus Nicolas, Guillermo Besne, Maria Bunuales, Manuela Gonzalez-Aparicio, Noemi Sola-Sevilla, Miguel Valencia, Ruben Hernandez-Alcoceba |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3becad7f781e4292b660db2d7710c5e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inhibitory synaptic transmission is impaired at higher extracellular Ca2+ concentrations in Scn1a +/− mouse model of Dravet syndrome
por: Kouya Uchino, et al.
Publicado: (2021) -
Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
por: Lyndsey L. Anderson, et al.
Publicado: (2017) -
Late diagnoses of Dravet syndrome: How many individuals are we missing?
por: Katri Silvennoinen, et al.
Publicado: (2021) -
Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms
por: Rao G, et al.
Publicado: (2017) -
Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations
por: Nadjet Belbachir, et al.
Publicado: (2021)